Comparison of the toxicity of amphotericin B in 5% dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1445-1448

  Nucci, Marcio ^a   Loureiro, Monique ^a   Silveira, Fernanda ^a   Casali, Anna Raquel ^b   Bouzas, Luis Fernando ^c   Velasco, Eduardo ^c   Spector, Nelson ^a   Pulcheri, Wolmar ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GLUCOSE; INTRALIPID; PETHIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLUS; CANCER PATIENT; CANDIDIASIS; CHILD; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEVER; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEPHROTOXICITY; PRIORITY JOURNAL; RHODOTORULA; RIGOR; TREATMENT OUTCOME;

EID: 0033031249     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1445     Document Type: Article

References (17)

1. Caillot, D., G. Reny, E. Solary, O. Casanovas, P. Chavanel, B. Bonnette, L. Perello, M. Dumas, F. Entezam, and H. Guy. 1994. A controlled trial of the tolerance of amphotericin B infused in dextrose or in Intralipid in patients with hematological malignancies. J. Antimicrob. Chemother. 33:603-613.
2. Chavanet, P. Y., I. Garry, N. Charlier, D. Caillot, J. P. Kisterman, M. D'Athis, and H. Portier. 1992. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV patients with candidiasis. Br. Med. J. 305:921-925.
3. Cruz, J. M., J. E. Peacock, L. Lomer, L. W. Holder, G. W. Evans, B. L. Powell, S. Lyerly, and R. L. Capizzi. 1992. Rapid intravenous infusion of amphotericin B: a pilot study. Am. J. Med. 93:123-130.
4. Gallis, H., R. Drew, and W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-328.
5. Goodwin, S. D., J. D. Cleary, C. A. Walawander, J. W. Taylor, and T. H. Grasela, Jr. 1995. Pretreatment regimens for adverse events related to infusion of amphotericin B. Clin. Infect. Dis. 20:755-761.
6. Graybill, J. R. 1996. Lipid formulations for amphotericin B: does the emperor need new clothes? Ann. Inter. Med. 1245:921-923.
7. Hoeprich, P. D. 1992. Clinical use of amphotericin B and derivatives: lore, mystique, and fact. Clin. Infect. Dis. 14(Suppl. 1):S114-S119.
8. Joly, V., P. Aubry, A. Ndayiragide, I. Carrière, E. Kawa, N. Milika-Cabanne, J. P. Aboulker, J. P. Coulaud, B. Larouze, and P. Yeni. 1996. Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis. Clin. Infect. Dis. 23:556-562.
9. Khoo, S. H., J. Bond, and D. W. Denning. 1994. Administering amphotericin B - a practical approach. J. Antimicrob. Chemother. 33:203-213.
10. Kirsh, R., R. Goldstein, J. Tarloff, D. Parris, J. Hook, N. Hanna, P. Bugelski, and G. Poste. 1988. An emulsion formulation of amphotericin B improves the therapeutic index when treating murine candidiasis. J. Infect. Dis. 158: 1065-1070.
11. Monges, P., A. Blancard, B. Lacarelle, J. P. Denis, J. P. Regnier, C. Pénot-Ragon, and F. Gouin. 1994. Lipid emulsion of amphotericin B: galenic stability and kinetic profile of perfusions; preliminary results. In Report from the French Society of Medical Mycology Meeting.
12. Moreau, P., N. Milpied, N. Fayette, J. F. Ramée, and J. L. Harousseau. 1992. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients. J. Antimicrob. Chemother. 30:535-541.
13. Pascual, B., A. Ayestaran, J. B. Montoro, J. Oliveras, A. Estibalez, A. Julia, and A. Lopez. 1995. Administration of lipid-emulsion versus conventional amphotericin b in patients with neutropenia. Ann. Pharmacother. 12:1197-1201.
14. Ranchere, J. Y., J. F. Latour, C. Lagallarde, and F. Larieul. 1994. Amphotericin B in lipid solution: stability and granulometry. In Report from the 14th Interdisciplinary Meeting on Anti-Infectious Chemotherapy.
15. Schoffski, P., M. Freund, R. Wunder, D. Petersen, C. H. Kohne, H. Hecker, U. Schubert, and A. Ganser. 1998. Safety and toxicity of amphotericin B in glucose 5% or Intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study. Br. Med. J. 317:379-384.
16. Sievers, T. M., B. M. Kubak, and A. Wong-Beringer. 1996. Safety and efficacy of Intralipid emulsions of amphotericin B. J. Antimicrob. Chemother. 38: 333-347.
17. Sorkine, P., H. Nagar, A. Weinbroum, A. Setton, E. Israitel, A. Scarlatt, A. Silbiger, V. Rudick, Y. Kluger, and P. Halpern. 1996. Administration of amphotericin b in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients. Crit. Care Med. 8:1311-1315.